Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation

Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation

Despite conventional treatment options including chemoradiation, patients with the most aggressive primary brain tumor, glioblastoma multiforme (GBM), experience an average survival time of less than 15 months. Regarding the malignant nature of GBM, extensive research and discovery of novel treatmen...

Full description

Bibliographic Details
Main Authors: Mehdi Sanati, Maryam Moradi Binabaj, Seyed Sajad Ahmadi, Samaneh Aminyavari, Hossein Javid, Hamid Mollazadeh, Bahram Bibak, Elmira Mohtashami, Tannaz Jamialahmadi, Amir R. Afshari, Amirhossein Sahebkar
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Glioblastoma
Autophagy
Therapy
Tumorigenesis
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332222011295

Internet

http://www.sciencedirect.com/science/article/pii/S0753332222011295

Similar Items